1. Home
  2. BRID vs EPRX Comparison

BRID vs EPRX Comparison

Compare BRID & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRID
  • EPRX
  • Stock Information
  • Founded
  • BRID 1932
  • EPRX 2011
  • Country
  • BRID United States
  • EPRX Canada
  • Employees
  • BRID N/A
  • EPRX N/A
  • Industry
  • BRID Specialty Foods
  • EPRX
  • Sector
  • BRID Consumer Staples
  • EPRX
  • Exchange
  • BRID Nasdaq
  • EPRX NYSE
  • Market Cap
  • BRID 93.2M
  • EPRX 109.7M
  • IPO Year
  • BRID N/A
  • EPRX N/A
  • Fundamental
  • Price
  • BRID $10.09
  • EPRX $3.65
  • Analyst Decision
  • BRID
  • EPRX Strong Buy
  • Analyst Count
  • BRID 0
  • EPRX 1
  • Target Price
  • BRID N/A
  • EPRX $9.00
  • AVG Volume (30 Days)
  • BRID 1.6K
  • EPRX 15.8K
  • Earning Date
  • BRID 03-07-2025
  • EPRX 03-04-2025
  • Dividend Yield
  • BRID N/A
  • EPRX N/A
  • EPS Growth
  • BRID N/A
  • EPRX N/A
  • EPS
  • BRID N/A
  • EPRX N/A
  • Revenue
  • BRID $223,645,000.00
  • EPRX N/A
  • Revenue This Year
  • BRID N/A
  • EPRX N/A
  • Revenue Next Year
  • BRID N/A
  • EPRX N/A
  • P/E Ratio
  • BRID N/A
  • EPRX N/A
  • Revenue Growth
  • BRID N/A
  • EPRX N/A
  • 52 Week Low
  • BRID $7.77
  • EPRX $2.20
  • 52 Week High
  • BRID $14.69
  • EPRX $4.08
  • Technical
  • Relative Strength Index (RSI)
  • BRID 43.86
  • EPRX N/A
  • Support Level
  • BRID $10.00
  • EPRX N/A
  • Resistance Level
  • BRID $10.31
  • EPRX N/A
  • Average True Range (ATR)
  • BRID 0.13
  • EPRX 0.00
  • MACD
  • BRID -0.03
  • EPRX 0.00
  • Stochastic Oscillator
  • BRID 27.57
  • EPRX 0.00

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are processing and distribution of frozen products, and processing and distribution of snack food products. It includes products such as biscuits, bread dough items, roll dough items, dry sausage products, and beef jerky. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. It derives a majority of its revenue from snack food products.

About EPRX EUPRAXIA PHARMACEUTICALS INC

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.

Share on Social Networks: